Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Literature
1.
Cathcart SJ, Sofronescu AG (2017) Clinically distinct presentations of copper deficiency myeloneuropathy and cytopenias in a patient using excessive zinc-containing denture adhesive. Clin Biochem 50:733–736CrossRefPubMed
2.
Lazarchick J (2012) Update on anemia and neutropenia in copper deficiency. Curr Opin Hematol 19:58–60CrossRefPubMed
3.
Gabreyes AA, Abbasi HN, Forbes KP, McQuaker G, Duncan A (2012) Hypocupremia associated cytopenias and myelopathy: a national retrospective review. Eur J Haematol 90:1–9CrossRefPubMed
4.
Irving JA, Mattman A, Lockitch G, Farrell K, Wadsworth LD (2003) Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation. CMAJ 169(2):129–131PubMedCentralPubMed
5.
Myint ZW, Oo TH, Thein KZ, Tun AM, Saeed H (2018 Sep) Copper deficiency anemia: review article. Ann Hematol 97(9):1527–1534CrossRefPubMed
Metadata
Title
An under-recognized cause of copper deficiency mimicking myelodysplastic syndrome
Authors
Margaret A. Stafford
Ming Y. Lim
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3512-5

Other articles of this Issue 4/2019

Annals of Hematology 4/2019 Go to the issue

Review Article

High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma

Letter to the Editor

Therapeutic strategies for durable response in plasma cell granulomas in the central nervous system

Original Article

Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia.

Letter to the Editor

Secondary diffuse large B cell lymphoma of the central nervous system: retrospective review of case series

Original Article

Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia

Original Article

Treatment patterns and comparative analysis of non-intensive regimens in elderly acute myeloid leukemia patients—a real-world experience from India
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits